An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome

Clinical Endocrinology

Volumn 78, Issue 6, 2013, Pages 907-913

  O'Gorman, Clodagh S ^a,b,c   Syme, Catriona ^b   Lang, Jun ^a   Bradley, Timothy J ^a   Wells, Greg D ^a,b   Hamilton, Jill K ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; ESTROGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LEVOTHYROXINE; LIPID; LOW DENSITY LIPOPROTEIN; RECOMBINANT GROWTH HORMONE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CANADA; CARDIOMETABOLIC RISK; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; FEMALE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SECRETION SENSITIVITY INDEX; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID ANALYSIS; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RATING SCALE; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STANDARD DEVIATION SCORE; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; TURNER SYNDROME; WAIST CIRCUMFERENCE;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; SUBCUTANEOUS FAT; TRIGLYCERIDES; TURNER SYNDROME; WAIST CIRCUMFERENCE;

EID: 84876519207     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12079     Document Type: Article

References (35)

1. Hall, J.G., &, Gilchrist, D.M., (1990) Turner syndrome and its variants. Pediatric Clinics of North America, 37, 1421-1440.
2. Ostberg, J.E., Donald, A.E., Halcox, J.P., et al,. (2005) Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. Journal of Clinical Endocrinology and Metabolism, 90, 5161-5166.
3. Mortensen, K.H., Andersen, N.H., Hjerrild, B.E., et al,. (2012) Carotid intima-media thickness is increased in Turner syndrome: multifactorial pathogenesis depending on age, blood pressure, cholesterol and oestrogen treatment. Clinical Endocrinology (Oxf), 77, 844-851.
4. Gravholt, C.H., Hjerrild, B.E., Mosekilde, L., et al,. (2006) Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. European Journal of Endocrinology, 155, 583-592.
5. Gravholt, C.H., Juul, S., Naeraa, R.W., et al,. (1998) Morbidity in Turner syndrome. Journal of Clinical Epidemiology, 51, 147-158.
6. Retnakaran, R., Qi, Y., Goran, M.I., et al,. (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabetic Medicine, 26, 1198-1203.
7. Caprio, S., Boulware, S., Diamond, M., et al,. (1991) Insulin resistance: an early metabolic defect of Turner's syndrome. Journal of Clinical Endocrinology and Metabolism, 72, 832-836.
8. Gravholt, C.H., Naeraa, R.W., Nyholm, B., et al,. (1998) Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Diabetes Care, 21, 1062-1070.
9. Gravholt, C.H., Hansen, K.W., Erlandsen, M., et al,. (2006) Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. Journal of Hypertension, 24, 353-360.
10. Gravholt, C.H., Landin-Wilhelmsen, K., Stochholm, K., et al,. (2006) Clinical and epidemiological description of aortic dissection in Turner's syndrome. Cardiology Young, 16, 430-436.
11. Van, P.L., Bakalov, V.K., &, Bondy, C.A., (2006) Monosomy for the X-chromosome is associated with an atherogenic lipid profile. Journal of Clinical Endocrinology and Metabolism, 91, 2867-2870.
12. Wells, G.D., Noseworthy, M.D., Hamilton, J., et al,. (2008) Skeletal muscle metabolic dysfunction in obesity and metabolic syndrome. Canadian Journal of Neurological Sciences, 35, 31-40.
13. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. (2008) Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes, 32(suppl 1), S1-S201.
14. Anon. (2002) CDC on-line BMI calculator. Vol. 2011. CDC, Atlanta.
15. Horlick, M., Arpadi, S.M., Bethel, J., et al,. (2002) Bioelectrical impedance analysis models for prediction of total body water and fat-free mass in healthy and HIV-infected children and adolescents. American Journal of Clinical Nutrition, 76, 991-999.
16. Wells, G.D., Wilkes, D.L., Schneiderman-Walker, J., et al,. (2008) Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis. Pediatric Pulmonology, 43, 345-353.
17. Rockett, H.R., Breitenbach, M., Frazier, A.L., et al,. (1997) Validation of a youth/adolescent food frequency questionnaire. Preventive Medicine, 26, 808-816.
18. Sinha, R., Dufour, S., Petersen, K.F., et al,. (2002) Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes, 51, 1022-1027.
19. Caprio, S., Hyman, L.D., Limb, C., et al,. (1995) Central adiposity and its metabolic correlates in obese adolescent girls. American Journal of Physiology, 269, E118-E126.
20. Provencher, S.W., (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med, 30, 672-679.
21. Anon. (2001) Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Heart, Lung, and Blood Institute, NIH, Bethesda, MD.
22. Alberti, K.G., &, Zimmet, P.Z., (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553.
23. Weiss, R., Dziura, J., Burgert, T.S., et al,. (2004) Obesity and the metabolic syndrome in children and adolescents. New England Journal of Medicine, 350, 2362-2374.
24. Simoneau-Roy, J., O'Gorman, C., Pencharz, P., et al,. (2011) Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma. BMC Endocrine Disorders (Oxf), 11, 6.
25. Hassink, S.G., Sheslow, D.V., de Lancey, E., et al,. (1996) Serum leptin in children with obesity: relationship to gender and development. Pediatrics, 98, 201-203.
26. Carleton, R.A., Dwyer, J., Finberg, L., et al,. (1991) Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation, 83, 2154-2232.
27. Matsuda, M., &, DeFronzo, R.A., (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
28. Retnakaran, R., Shen, S., Hanley, A.J., et al,. (2008) Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring), 16, 1901-1907.
29. Weigensberg, M.J., Cruz, M.L., &, Goran, M.I., (2003) Association between insulin sensitivity and post-glucose challenge plasma insulin values in overweight Latino youth. Diabetes Care, 26, 2094-2099.
30. Bakalov, V.K., Cooley, M.M., Quon, M.J., et al,. (2004) Impaired insulin secretion in the Turner metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 89, 3516-3520.
31. Simoneau-Roy, J., O'Gorman, C., Pencharz, P., et al,. (2010) Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma. Clinical Endocrinology (Oxf), 72, 364-370.
32. Bakalov, V.K., Cheng, C., Zhou, J., et al,. (2009) X-chromosome gene dosage and the risk of diabetes in Turner syndrome. Journal of clinical endocrinology and metabolism, 94, 3289-3296.
33. Gravholt, C.H., &, Weis Naeraa, R., (1997) Reference values for body proportions and body composition in adult women with Ullrich-Turner syndrome. American Journal of Medical Genetics, 72, 403-408.
34. Ostberg, J.E., Thomas, E.L., Hamilton, G., et al,. (2005) Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. Journal of clinical endocrinology and metabolism, 90, 2631-2635.
35. Weiss, R., Dufour, S., Taksali, S.E., et al,. (2003) Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet, 362, 951-957.